Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sarepta Therapeutics, Inc. (SRPT) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Sarepta Therapeutics, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 873303.
Total stock buying since 2005: $52,125,608.
Total stock sales since 2005: $170,656,948.
Total stock option exercises since 2005: $28,350,795.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2025 | 0 | $0 | 2,491 | $248,203 | 144,642 | $1,231,667 |
2024 | 37,038 | $4,960,499 | 96,566 | $14,056,256 | 95,250 | $2,036,050 |
2023 | 143,757 | $13,292,291 | 15,000 | $1,600,800 | 30,000 | $870,900 |
2022 | 103,270 | $10,980,220 | 858 | $94,311 | 20,000 | $698,400 |
2021 | 28,806 | $2,300,445 | 15,000 | $1,263,900 | 20,967 | $611,100 |
2020 | 0 | $0 | 188,487 | $30,358,072 | 133,260 | $2,774,674 |
2019 | 43,152 | $4,846,856 | 455,000 | $58,762,762 | 582,185 | $11,906,011 |
2018 | 32,695 | $4,017,625 | 282,973 | $37,226,372 | 221,125 | $2,904,632 |
2017 | 85,196 | $3,999,921 | 131,223 | $5,746,828 | 198,320 | $1,825,833 |
2016 | 154,500 | $2,470,070 | 177,703 | $8,941,400 | 157,842 | $1,475,161 |
2015 | 1,600 | $18,904 | 0 | $0 | 0 | $0 |
2013 | 35,500 | $1,050,758 | 21,489 | $394,449 | 5,556 | $97,341 |
2012 | 47,500 | $296,887 | 53,000 | $1,027,029 | 0 | $0 |
2011 | 570,000 | $572,700 | 0 | $0 | 0 | $0 |
2010 | 278,107 | $386,606 | 5,784,411 | $7,991,553 | 1,617,000 | $1,919,026 |
2009 | 949,400 | $960,929 | 333,950 | $475,878 | 0 | $0 |
2008 | 1,267,252 | $1,910,397 | 119,048 | $141,458 | 0 | $0 |
2006 | 5,000 | $31,800 | 840,000 | $2,327,677 | 0 | $0 |
2005 | 12,000 | $28,700 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2017-07-20 | Howton David T (SVP, General Counsel) | Option Ex | 25,000 | 13.71 | 342,750 |
2017-07-20 | Kaye Edward M. Md (Director) | Sale | 10,000 | 41.00 | 410,000 |
2017-07-20 | Mahatme Sandesh (EVP, CFO & CBO) | Sale | 50,000 | 41.00 | 2,050,000 |
2017-07-20 | Mahatme Sandesh (EVP, CFO & CBO) | Option Ex | 50,000 | 17.15 | 857,649 |
2016-11-09 | Howton David T (SVP, General Counsel) | Option Ex | 1,000 | 23.85 | 23,850 |
2016-11-09 | Kaye Edward M. Md (President, CEO & CMO) | Option Ex | 3,000 | 8.28 | 24,839 |
2016-11-09 | Mahatme Sandesh (Senior Vice President, CFO) | Option Ex | 1,000 | 23.85 | 23,850 |
2016-11-08 | Ruff Shamim (SVP, Regulatory Affairs & Qual) | Option Ex | 1,000 | 26.24 | 26,240 |
2016-10-17 | Mahatme Sandesh (Senior Vice President, CFO) | Sale | 30,000 | 50.08 | 1,502,490 |
2016-10-17 | Mahatme Sandesh (Senior Vice President, CFO) | Option Ex | 30,000 | 13.90 | 417,000 |
2016-09-22 | Ruff Shamim (SVP, Regulatory Affairs & Qual) | Sale | 7,311 | 60.00 | 438,660 |
2016-09-22 | Ruff Shamim (SVP, Regulatory Affairs & Qual) | Option Ex | 7,311 | 13.90 | 101,622 |
2016-09-22 | Howton David T (SVP, General Counsel) | Sale | 7,000 | 60.00 | 420,000 |
2016-09-22 | Howton David T (SVP, General Counsel) | Option Ex | 7,000 | 13.90 | 97,300 |
2016-09-22 | Kaye Edward M. Md (President, CEO & CMO) | Sale | 40,179 | 60.00 | 2,410,740 |
2016-09-22 | Kaye Edward M. Md (President, CEO & CMO) | Option Ex | 40,179 | 8.28 | 332,682 |
2016-09-19 | Aphale Jayant (VP, Technical Operations) | Sale | 35,000 | 50.00 | 1,750,000 |
2016-09-19 | Aphale Jayant (VP, Technical Operations) | Option Ex | 35,000 | 4.62 | 161,700 |
2016-09-19 | Howton David T (SVP, General Counsel) | Sale | 9,304 | 50.00 | 465,200 |
2016-09-19 | Howton David T (SVP, General Counsel) | Option Ex | 8,000 | 13.90 | 111,200 |
2016-09-19 | Kaye Edward M. Md (President, CEO & CMO) | Sale | 24,352 | 50.00 | 1,217,600 |
2016-09-19 | Kaye Edward M. Md (President, CEO & CMO) | Option Ex | 24,352 | 6.36 | 154,878 |
2016-09-14 | Kaye Edward M. Md (SVP Interim CEO & CMO) | Sale | 24,557 | 30.00 | 736,710 |
2016-03-16 | Behrens M Kathleen (Director) | Buy | 10,000 | 14.54 | 145,430 |
2016-03-14 | Barry Richard (Director) | Buy | 75,000 | 15.66 | 1,174,200 |
2016-03-14 | Price Ben Gil (Director) | Buy | 4,500 | 16.70 | 75,145 |
2016-03-14 | Behrens M Kathleen (Director) | Buy | 65,000 | 16.54 | 1,075,295 |
2015-02-27 | Kaye Edward M. Md (SVP & Chief Medical Officer) | Buy | 800 | 11.81 | 9,452 |
2015-02-27 | Christopher Nishan Garabedian (President and CEO) | Buy | 800 | 11.81 | 9,452 |
2013-11-14 | Chase Anthony R (Director) | Buy | 10,000 | 13.95 | 139,480 |
2013-11-12 | Aphale Jayant (SVP Technical Operations) | Sale | 15,933 | 12.56 | 200,134 |
2013-09-16 | Behrens M Kathleen (Director) | Buy | 6,500 | 37.04 | 240,779 |
2013-09-03 | Hodgman John (Director) | Sale | 5,556 | 34.97 | 194,315 |
2013-09-03 | Hodgman John (Director) | Option Ex | 5,556 | 17.52 | 97,341 |
2013-08-22 | Chase Anthony R (Director) | Buy | 3,500 | 32.68 | 114,372 |
2013-08-20 | Mahatme Sandesh (Senior Vice President, CFO) | Buy | 5,000 | 31.10 | 155,500 |
2013-08-19 | Price Ben Gil (Director) | Buy | 500 | 31.18 | 15,587 |
2013-06-14 | Chase Anthony R (Director) | Buy | 10,000 | 38.50 | 385,040 |
2012-11-28 | Chase Anthony R (Director) | Sale | 8,900 | 29.36 | 261,286 |
2012-11-27 | Chase Anthony R (Director) | Sale | 1,100 | 29.04 | 31,940 |
2012-11-14 | Chase Anthony R (Director) | Sale | 10,000 | 25.96 | 259,560 |
2012-09-07 | Chase Anthony R (Director) | Sale | 33,000 | 14.37 | 474,243 |
2012-09-07 | Behrens M Kathleen (Director) | Buy | 17,500 | 14.74 | 258,037 |
2012-03-14 | Price Ben Gil (Director) | Buy | 30,000 | 1.29 | 38,850 |
2011-12-15 | Christopher Nishan Garabedian (President and CEO) | Buy | 300,000 | .58 | 173,700 |
2011-09-13 | Chase Anthony R (Director) | Buy | 20,000 | 1.20 | 24,000 |
2011-04-06 | Christopher Nishan Garabedian (President and CEO) | Buy | 130,000 | 1.50 | 195,000 |
2011-04-06 | Price Ben Gil (Director) | Buy | 20,000 | 1.50 | 30,000 |
2011-04-06 | Behrens M Kathleen (Director) | Buy | 100,000 | 1.50 | 150,000 |
2010-08-27 | Boyle J David Ii (CEO) | Buy | 5,000 | 2.13 | 10,645 |
2010-08-13 | Price Ben Gil (Director) | Buy | 4,000 | 1.93 | 7,720 |
2010-07-30 | Hudson Leslie (Former CEO) | Sale | 183,486 | 1.93 | 354,127 |
2010-07-30 | Hudson Leslie (Former CEO) | Option Ex | 183,486 | 1.09 | 199,999 |
2010-07-28 | Hudson Leslie (Former CEO) | Sale | 183,486 | 1.83 | 335,412 |
2010-07-28 | Hudson Leslie (Former CEO) | Option Ex | 183,486 | 1.09 | 199,999 |
2010-07-26 | Hudson Leslie (Former CEO) | Sale | 129,083 | 1.91 | 246,161 |
2010-07-26 | Hudson Leslie (Former CEO) | Option Ex | 129,083 | 1.45 | 187,170 |
2010-07-23 | Hudson Leslie (Former CEO) | Sale | 205,400 | 1.80 | 369,720 |
2010-07-23 | Hudson Leslie (Former CEO) | Option Ex | 205,400 | 1.45 | 297,830 |
2010-07-22 | Hudson Leslie (Former CEO) | Sale | 265,517 | 1.80 | 477,930 |
2010-07-22 | Hudson Leslie (Former CEO) | Option Ex | 265,517 | 1.45 | 384,999 |
2010-07-16 | Hudson Leslie (Former CEO) | Sale | 100,028 | 1.88 | 187,652 |
2010-07-16 | Hudson Leslie (Former CEO) | Option Ex | 100,028 | 1.09 | 109,030 |
2010-07-09 | Hudson Leslie (Former CEO) | Sale | 200,000 | 1.59 | 317,800 |
2010-07-09 | Hudson Leslie (Former CEO) | Option Ex | 200,000 | 1.09 | 218,000 |
2010-07-07 | Hudson Leslie (Former CEO) | Sale | 200,000 | 1.47 | 294,400 |
2010-07-07 | Hudson Leslie (Former CEO) | Option Ex | 200,000 | .92 | 184,000 |
2010-07-06 | Hudson Leslie (Former CEO) | Sale | 21,089 | 1.53 | 32,371 |
2010-07-06 | Hudson Leslie (Former CEO) | Option Ex | 21,089 | .92 | 19,401 |
2010-07-02 | Hudson Leslie (Former CEO) | Sale | 128,911 | 1.57 | 203,034 |
2010-07-02 | Hudson Leslie (Former CEO) | Option Ex | 128,911 | .92 | 118,598 |
2010-06-24 | Hudson Leslie (Former CEO) | Sale | 51,338 | 1.24 | 63,659 |
2010-06-11 | Price Ben Gil (Director) | Buy | 7,000 | 1.44 | 10,080 |
2010-06-09 | Chase Anthony R (Director) | Buy | 46,500 | 1.41 | 65,751 |
2010-05-21 | Chase Anthony R (Director) | Buy | 50,000 | 1.33 | 66,500 |
2010-05-18 | Chase Anthony R (Director) | Buy | 11,068 | 1.43 | 15,771 |
2010-05-17 | Chase Anthony R (Director) | Buy | 18,539 | 1.41 | 26,139 |
2010-05-13 | Price Ben Gil (Director) | Buy | 40,000 | 1.36 | 54,400 |
2010-05-12 | Chase Anthony R (Director) | Buy | 96,000 | 1.35 | 129,600 |
2010-03-24 | Hudson Leslie (Former CEO) | Sale | 21,427 | 1.49 | 31,926 |
2010-03-04 | Eastbourne Capital Management Llc/ca (10% Owner) | Sale | 4,094,646 | 1.24 | 5,077,361 |
2009-11-11 | Eastbourne Capital Management Llc/ca (10% Owner) | Sale | 333,950 | 1.43 | 475,878 |
2009-08-25 | Haywood George Weaver (Other) | Buy | 430,000 | .68 | 290,250 |
2009-08-21 | Haywood George Weaver (Other) | Buy | 450,000 | 1.39 | 625,500 |
2009-03-16 | Price Ben Gil (Director) | Buy | 20,400 | .67 | 13,688 |
2009-03-13 | Price Ben Gil (Director) | Buy | 30,000 | .65 | 19,350 |
2009-03-13 | Boyle J David Ii (CFO) | Buy | 19,000 | .64 | 12,141 |
2008-09-03 | Kole Ryszard (Senior Vice President) | Sale | 38,200 | 1.12 | 42,745 |
2008-09-02 | Kole Ryszard (Senior Vice President) | Sale | 61,800 | 1.13 | 69,586 |
2008-08-15 | Price Ben Gil (Director) | Buy | 6,582 | 1.22 | 8,030 |
2008-06-03 | Kole Ryszard (Senior Vice President) | Sale | 4,048 | 1.40 | 5,667 |
2008-05-20 | Kole Ryszard (SENIOR VICE PRESIDENT) | Sale | 15,000 | 1.56 | 23,460 |
2008-03-31 | Haywood George Weaver (10% Owner) | Buy | 156,423 | 1.83 | 286,254 |
2008-03-27 | Haywood George Weaver (10% Owner) | Buy | 27,842 | 1.75 | 48,723 |
2008-03-26 | Haywood George Weaver (10% Owner) | Buy | 100,000 | 1.74 | 174,000 |
2008-03-25 | Haywood George Weaver (10% Owner) | Buy | 100,000 | 1.72 | 172,000 |
2008-03-24 | Haywood George Weaver (10% Owner) | Buy | 100,400 | 1.50 | 150,600 |
2008-03-12 | Haywood George Weaver (10% Owner) | Buy | 110,130 | 1.44 | 158,587 |
2008-03-11 | Haywood George Weaver (10% Owner) | Buy | 55,375 | 1.39 | 76,971 |
2008-03-10 | Haywood George Weaver (10% Owner) | Buy | 37,300 | 1.28 | 47,744 |
2008-02-20 | Haywood George Weaver (10% Owner) | Buy | 11,000 | 1.41 | 15,510 |
2008-02-19 | Haywood George Weaver (10% Owner) | Buy | 100,000 | 1.41 | 141,000 |
2008-02-15 | Haywood George Weaver (10% Owner) | Buy | 7,200 | 1.34 | 9,648 |
2008-02-13 | Haywood George Weaver (10% Owner) | Buy | 150,000 | 1.42 | 212,700 |
2008-02-12 | Haywood George Weaver (10% Owner) | Buy | 240,000 | 1.38 | 330,240 |
2008-02-11 | Haywood George Weaver (10% Owner) | Buy | 65,000 | 1.21 | 78,390 |
2006-08-10 | Haywood George Weaver (10% Owner) | Sale | 35,940 | 2.68 | 96,318 |
2006-08-09 | Haywood George Weaver (10% Owner) | Sale | 164,060 | 2.71 | 444,602 |
2006-07-27 | Haywood George Weaver (10% Owner) | Sale | 360,300 | 2.71 | 975,692 |
2006-07-26 | Haywood George Weaver (10% Owner) | Sale | 36,000 | 2.95 | 106,200 |
2006-07-25 | Haywood George Weaver (10% Owner) | Sale | 143,700 | 3.02 | 434,405 |
2006-03-17 | Bowman Jack L (Director) | Buy | 5,000 | 6.36 | 31,800 |
2005-11-23 | Hicks James B (Director) | Buy | 2,000 | 3.37 | 6,740 |
2005-09-07 | Forrest K Michael (Director) | Buy | 10,000 | 2.20 | 21,960 |
Insider trading activities including stock purchases, stock sales, and option exercises of SRPT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Sarepta Therapeutics, Inc. (symbol SRPT, CIK number 873303) see the Securities and Exchange Commission (SEC) website.